Alan Carter
Alan Carter is a seasoned professional with a diverse background in healthcare, wellness, and business development.
With a Bachelor of Arts in Chemistry from Virginia Tech and a strong educational foundation from The Heathcote School, Stevenage, Alan is well-equipped for navigating the complexities of the industry.
Alan has held key positions in multiple organizations, showcasing his expertise and leadership abilities.
He currently serves as the COE (Chief Opportunity Explorer) at a Stealth Mode Startup, where he focuses on pioneering solutions in the ever-evolving healthcare landscape.
Alan has previously held significant roles including President at MDx Consulting, Clinical Business Development at BioDiscovery, and Founding President at DNAFour, demonstrating his versatile skill set.
His experience extends to roles such as Founding Executive Director at Wobblebase Inc., Clinical Market Development Director at Complete Genomics Inc., and Vice President of Business Development at Agendia, BV.
Additionally, Alan has served as Vice President of Business Development at Verdezyne, Chief of Commercial Operations at Biotrove, Inc. (now Life Technologies), Director of Business Development at Gene Logic, and Director of Sales at Celera.
Alan Carter's career is marked by a commitment to exploring disruptions in healthcare and wellness, making him a valuable asset in addressing current challenges and future uncertainties.